Advertisement

Aesthetic Plastic Surgery

, Volume 32, Issue 4, pp 705–709 | Cite as

Intralesional Triamcinolone Acetonide for Keloid Treatment: A Systematic Review

  • B. HochmanEmail author
  • R. F. Locali
  • P. K. Matsuoka
  • L. M. Ferreira
Letter to the Editor

Introduction

The keloid lesion is a hypertrophic scar dysfunction with continuous growth and tumoral shape that usually presents with a hyperemic aspect accompanied by pruritus and pain [6, 12]. This disease can have a prevalence reaching 16% in dark-skinned populations. Those who carry the disease will experience psychosocial impairment and loss of quality of life [16].

The physiopathogenesis of keloids is not completely clear in the medical literature, although it has been the focus of many studies, and this has led to empirical treatments with debatable success [7, 15]. One of the most frequently used treatments is intralesional corticotherapy with triamcinolone acetonide, isolated or in association [10].

However, the literature presents no consensus on the ideal drug concentration for injection into the keloidal scar. Therefore, this study aimed to explore the most effective concentration and application periodicity of triamcinolone acetonide for intralesional injections in keloids.

Keywords

Triamcinolone Acetonide Review Protocol Intralesional Injection Inferential Analysis Keloid Scar 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117:286–300PubMedCrossRefGoogle Scholar
  2. 2.
    Campaner AB, Ferreira LM, Gragnani A, Bruder JM, Cusick JL, Morgan JR (2006) Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol 126:1168–1176PubMedCrossRefGoogle Scholar
  3. 3.
    Diegelmann RF, Bryant CP, Cohen IK (1977) Tissue alpha-globulins in keloid formation. Plast Reconstr Surg 59:418–423PubMedCrossRefGoogle Scholar
  4. 4.
    Golladay ES (1988) Treatment of keloids by single intraoperative perilesional injection of repository steroid. South Med J 81:736–738PubMedCrossRefGoogle Scholar
  5. 5.
    Hochman B, Ferreira LM, Vilas Bôas FC, Mariano M (2004) Experimental model in hamster (Mesocricetus auratus) to study heterologous graft of scars and cutaneous diseases in plastic surgery. Acta Cir Bras 19:69–78Google Scholar
  6. 6.
    Hochman B, Ferreira LM, Vilas Bôas FC, Mariano M (2004) Hamster (Mesocricetus auratus) cheek pouch as an experimental model to investigate human skin and keloid heterologous graft. Acta Cir Bras 19:79–88Google Scholar
  7. 7.
    Hochman B, Vilas Bôas FC, Mariano M, Ferreira LM (2005) Keloid heterograft in the hamster (Mesocricetus auratus) cheek pouch. Acta Cir Bras 20:200–212PubMedGoogle Scholar
  8. 8.
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12PubMedCrossRefGoogle Scholar
  9. 9.
    Kelly AP (2004) Medical and surgical therapies for keloids. Dermatol Ther 17:212–218PubMedCrossRefGoogle Scholar
  10. 10.
    Ketchum LD, Smith J, Robinson DW, Masters FW (1966) The treatment of hypertrophic scar, keloid, and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 38:209–218PubMedCrossRefGoogle Scholar
  11. 11.
    Ketchum LD, Robinson DW, Masters FW (1971) Follow-up on treatment of hypertrophic scars and keloids with triamcinolone. Plast Reconstr Surg 48:256–259PubMedCrossRefGoogle Scholar
  12. 12.
    Lee SS, Yosipovitch G, Chan YH, Goh CL (2004) Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 51:1002–1006PubMedCrossRefGoogle Scholar
  13. 13.
    Leventhal D, Furr M, Reiter D (2006) Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 8:362–368PubMedCrossRefGoogle Scholar
  14. 14.
    Locali RF, Buffolo E, Catani R (2006) Artéria radial versus veia safena para revascularização do miocárdio: metanálise (não houve diferença estatisticamente significante). Braz J Cardiovasc Surg 21:255–261Google Scholar
  15. 15.
    Olabanji JK, Onayemi O, Olasode OA, Lawai OAR (2005) Keloids: an old problem still searching for a solution. Surg Pract 9:2–7Google Scholar
  16. 16.
    O’Sullivan ST, O’Shaughnessy M, O’Connor TP (1996) Aetiology and management of hypertrophic scars and keloids. Ann R Coll Surg Engl 78:168–175PubMedGoogle Scholar
  17. 17.
    Poochareon VN, Berman B (2003) New therapies for the management of keloids. J Craniofac Surg 14:654–657PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • B. Hochman
    • 1
    Email author
  • R. F. Locali
    • 1
  • P. K. Matsuoka
    • 1
  • L. M. Ferreira
    • 1
  1. 1.Division of Plastic SurgeryFederal University of São Paulo (UNIFESP)São PauloBrazil

Personalised recommendations